Stocks NYAX Financial statements
Financial statementsNayax Ltd. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Nayax Ltd. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | 78.8 | 119 | 174 | 235 | 314 | 400 |
| Cost of revenue | 41.6 | 71 | 113 | 147 | 172 | 207 |
| Gross profit | 37.2 | 48.2 | 60 | 88.3 | 142 | 193 |
| Research and development | 9.3 | 19 | 22.1 | 21.9 | 25.4 | 30 |
| Selling, general and administrative | 26.5 | 45.4 | 64.1 | 70.3 | 98.2 | 121 |
| Operating income | -2.22 | -22.5 | -34 | -12.4 | 3.11 | 37.6 |
| Interest expense | 3.87 | 1.66 | 3.46 | 4.78 | 10.9 | 13.7 |
| Interest income | 0.44 | 2.49 | 3.41 | 10.7 | ||
| Pre-tax income | -6.1 | -24.1 | -37.1 | -14.7 | -4.38 | 34.6 |
| Income tax | -0.02 | 0.63 | 0.45 | 1.22 | 1.25 | -0.95 |
| Net income to minority interests | 0.17 | -0.01 | 0 | 0 | ||
| Net income | -6.08 | -24.8 | -37.5 | -15.9 | -5.63 | 35.5 |
| EBITDA | -0.66 | -20.3 | -30.7 | -7.94 | 10.6 | 46.2 |
| EPS, basic | -0.25 | -0.82 | -1.14 | -0.48 | -0.16 | 0.96 |
| EPS, diluted | -0.25 | -0.82 | -1.14 | -0.48 | -0.16 | 0.94 |
Balance sheet
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 8.2 | 87.3 | 33.9 | 38.4 | 83.1 | 320 |
| Receivables | 19.3 | 27.4 | 41.3 | 55.7 | 104 | |
| Inventory | 7.69 | 23.8 | 20.6 | 19.8 | 28.6 | |
| Total current assets | 156 | 150 | 203 | 288 | 620 | |
| Property, plant and equipment | 5.05 | 6.23 | 6.67 | 5.49 | 11.1 | 20.4 |
| Lease right-of-use assets | 4.76 | 5.28 | 7.38 | 5.34 | 6.29 | 8.91 |
| Total assets | 216 | 230 | 324 | 433 | 853 | |
| Short-term debt | 0 | 7.68 | 47.5 | 25.3 | 0 | |
| Total current liabilities | 70.2 | 110 | 204 | 219 | 274 | |
| Lease liabilities | 5.15 | 5.39 | 5.94 | 4.15 | 4.08 | 6.4 |
| Total liabilities | 84.3 | 126 | 226 | 268 | 622 | |
| Retained earnings | -28.7 | -56.6 | -65.6 | -63.3 | -19.6 | |
| Shareholders' equity | 132 | 105 | ||||
| Total equity | 12.5 | 132 | 105 | 97.6 | 165 | 231 |
| Total liabilities and equity | 216 | 230 | 324 | 433 | 853 |
Cash flow statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | -6.08 | -24.8 | -37.5 | -15.9 | -5.63 | 35.5 |
| Depreciation and amortization | 1.56 | 2.2 | 3.37 | 4.44 | 7.48 | 8.66 |
| Cash from operations | 6.49 | -12.8 | -27.5 | 8.8 | 42.9 | 40.3 |
| Capital expenditures | -2.13 | -2.64 | -1.52 | -0.61 | -3.08 | -5.33 |
| Cash from investing | -8.57 | -22.6 | -26.5 | -36.8 | -45.9 | -78.7 |
| Debt issued | 4.73 | -1.97 | 0 | 0 | 22.8 | 0 |
| Debt repaid | -0.92 | -2.18 | -2.58 | -3.63 | -3.84 | 0 |
| Stock issued | 0 | 133 | 0 | 0 | ||
| Cash from financing | 6.05 | 114 | 6.21 | 31.6 | 50.8 | 266 |
| Exchange rate effect | -0.22 | 0.63 | -6.19 | 0.91 | -2.69 | 11.2 |
| Net change in cash | 3.96 | 78.7 | -47.9 | 3.52 | 47.8 | 227 |
| Free cash flow | 4.36 | -15.4 | -29.1 | 8.19 | 39.8 | 35 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 48.2% | Gross profit / revenue. |
| Operating margin | 9.4% | Operating income / revenue. |
| EBITDA margin | 11.5% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 8.6% | Pre-tax income / revenue. |
| Net margin | 8.9% | Net income / revenue. |
| FCF margin | 8.7% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 10.1% | Cash from operations / revenue. |
| Effective tax rate | -2.7% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on assets (ROA) | 5.5% | Net income / average total assets. |
| R&D / revenue | 7.5% | Research and development expense / revenue. |
| SG&A / revenue | 30.3% | Selling, general and administrative expense / revenue. |
| Capex / revenue | 1.3% | Capital expenditures / revenue. |
| D&A / revenue | 2.2% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 27.5% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 32.1% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 38.4% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 36.3% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 47.6% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 39.0% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 1,110.0% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | 336.5% | EBITDA vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | -6.1% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 5y | 44.1% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -12.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 5y | 51.6% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 97.0% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 54.7% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.26x | Current assets / current liabilities. |
| Quick ratio | 1.54x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.16x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 72.9% | Total liabilities / total assets. |
| Interest coverage | 2.75x | Operating income / interest expense. |
| Working capital | $345.7M | Current assets - current liabilities. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.62x | Revenue / average total assets. |
| Fixed asset turnover | 25.4x | Revenue / average property, plant and equipment. |
| Inventory turnover | 8.58x | Cost of revenue / average inventory. |
| Days inventory | 43 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 5.02x | Revenue / average receivables. |
| Days sales outstanding | 73 days | 365 x average receivables / revenue. |
| FCF conversion | 98.4% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 13.2% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.94 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.96 | Net income per basic share, as reported (split-adjusted). |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.68B | Share price x shares outstanding. |
| Enterprise value | $1.36B | Market cap + total debt - cash - short-term investments. |
| P/E | 47.4x | Market cap / net income. Only when net income is positive. |
| P/S | 4.20x | Market cap / revenue. |
| P/FCF | 48.1x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 41.8x | Market cap / cash from operations, when positive. |
| EV/Sales | 3.40x | Enterprise value / revenue. |
| EV/EBIT | 36.3x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 29.5x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 39.0x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 2.1% | Free cash flow / market cap. |
| Earnings yield | 2.1% | Net income / market cap (the inverse of P/E). |
What was Nayax Ltd.'s revenue in fiscal 2025?
Nayax Ltd. reported revenue of $400.4M for fiscal 2025, 27.5% higher than the year before.
Was Nayax Ltd. profitable in fiscal 2025?
Yes. Net income was $35.5M, a net margin of 8.9%.
How much free cash flow did Nayax Ltd. generate in fiscal 2025?
Cash from operations of $40.3M minus capital expenditures of $5.3M left free cash flow of $35.0M.